Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1016/j.pan.2019.11.012

The efficacy and toxicity of chemotherapy in the elderly with advanced pancreatic cancer

..., Tingbo Liang
37
Pancreatology3.60
Volume: 20, Issue: 1, Pages: 95 - 100
Published: Jan 1, 2020
Abstract
FOLFIRINOX (FFX) or abraxane plus gemcitabine (AG)-based chemotherapy is used widely as firstline treatment for patients with pancreatic cancer. However, their use in the elderly is discouraged because of adverse events. More clinical data about the therapeutic response and tolerability to FFX or AG in elderly patents (over 70 years old) are required. Patients with advanced pancreatic cancer (n = 203; 131 metastatic pancreatic cancer patients...
Paper Fields
Paper Details
Title
The efficacy and toxicity of chemotherapy in the elderly with advanced pancreatic cancer
DOI
doi.org/10.1016/j.pan.2019.11.012
Published Date
Jan 1, 2020
Journal
Pancreatology
Volume
20
Issue
1
Pages
95 - 100
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.